| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 3.83e-06 | 7 | 97 | 3 | GO:0004703 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 MYD88 ATP13A4 MYH9 ABCA4 CHD1 ABCA8 MSH6 MDN1 ATP11C ABCC2 ASCC3 | 4.22e-05 | 614 | 97 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | histone modifying activity | 1.27e-04 | 229 | 97 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 1.39e-04 | 4 | 97 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | histone H3K36me/H3K36me2 demethylase activity | 1.39e-04 | 4 | 97 | 2 | GO:0140680 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 4.83e-04 | 7 | 97 | 2 | GO:0090555 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 8.30e-07 | 157 | 98 | 8 | GO:0046467 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 1.42e-06 | 117 | 98 | 7 | GO:0030148 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 1.36e-05 | 229 | 98 | 8 | GO:0006643 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 1.81e-05 | 172 | 98 | 7 | GO:0043604 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 2.10e-05 | 176 | 98 | 7 | GO:0006665 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | HACD3 GAL3ST1 AMACR SMPD4 CYP39A1 LDLR ABCA8 ELOVL7 CERS5 MECR ST3GAL5 PIK3CD ATM MPPE1 | 2.95e-05 | 813 | 98 | 14 | GO:0008610 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.48e-05 | 230 | 100 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 3.04e-05 | 185 | 100 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.20e-04 | 230 | 100 | 7 | GO:0098562 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.03e-04 | 112 | 100 | 5 | GO:0055038 | |
| GeneOntologyCellularComponent | recycling endosome | 6.97e-04 | 222 | 100 | 6 | GO:0055037 | |
| Domain | GPCR_kinase | 5.13e-06 | 7 | 100 | 3 | IPR000239 | |
| Domain | RGS | 5.51e-05 | 39 | 100 | 4 | IPR016137 | |
| Domain | RFX1_trans_act | 8.48e-05 | 3 | 100 | 2 | IPR007668 | |
| Domain | RFX1_trans_act | 8.48e-05 | 3 | 100 | 2 | PF04589 | |
| Domain | PHD_4 | 8.48e-05 | 3 | 100 | 2 | PF16866 | |
| Domain | Neurofascin/L1/NrCAM_C | 1.69e-04 | 4 | 100 | 2 | IPR026966 | |
| Domain | Bravo_FIGEY | 1.69e-04 | 4 | 100 | 2 | PF13882 | |
| Domain | FAT | 4.20e-04 | 6 | 100 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 4.20e-04 | 6 | 100 | 2 | IPR003151 | |
| Domain | Znf_PHD-finger | 8.55e-04 | 79 | 100 | 4 | IPR019787 | |
| Domain | RGS | 8.61e-04 | 35 | 100 | 3 | PF00615 | |
| Domain | RGS | 8.61e-04 | 35 | 100 | 3 | SM00315 | |
| Domain | RGS | 9.35e-04 | 36 | 100 | 3 | PS50132 | |
| Domain | RFX_DNA_binding | 9.97e-04 | 9 | 100 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 9.97e-04 | 9 | 100 | 2 | IPR003150 | |
| Domain | RFX_DBD | 9.97e-04 | 9 | 100 | 2 | PS51526 | |
| Domain | AAA | 1.06e-03 | 144 | 100 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.06e-03 | 144 | 100 | 5 | IPR003593 | |
| Domain | PHD | 1.33e-03 | 89 | 100 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.45e-03 | 91 | 100 | 4 | IPR001965 | |
| Domain | ZF_CXXC | 1.51e-03 | 11 | 100 | 2 | PS51058 | |
| Domain | Znf_CXXC | 1.51e-03 | 11 | 100 | 2 | IPR002857 | |
| Domain | zf-CXXC | 1.51e-03 | 11 | 100 | 2 | PF02008 | |
| Domain | ZF_PHD_2 | 1.70e-03 | 95 | 100 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.76e-03 | 96 | 100 | 4 | PS01359 | |
| Domain | ABC_A | 1.81e-03 | 12 | 100 | 2 | IPR026082 | |
| Domain | P-loop_NTPase | DNHD1 MYH9 ABCA4 GAL3ST1 CHD1 ABCA8 MSH6 SPATA17 MDN1 GNAS ABCC2 ASCC3 | 1.90e-03 | 848 | 100 | 12 | IPR027417 |
| Domain | ABC_tran | 2.16e-03 | 48 | 100 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.16e-03 | 48 | 100 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.30e-03 | 49 | 100 | 3 | PS00211 | |
| Domain | ABC_transporter-like | 2.43e-03 | 50 | 100 | 3 | IPR003439 | |
| Domain | PI3/4_kinase_CS | 2.85e-03 | 15 | 100 | 2 | IPR018936 | |
| Domain | LY | 2.85e-03 | 15 | 100 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.85e-03 | 15 | 100 | 2 | IPR000033 | |
| Domain | - | 3.24e-03 | 16 | 100 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.24e-03 | 16 | 100 | 2 | SM00146 | |
| Domain | AT_hook | 3.24e-03 | 16 | 100 | 2 | PF02178 | |
| Domain | AGC-kinase_C | 3.36e-03 | 56 | 100 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.36e-03 | 56 | 100 | 3 | PS51285 | |
| Domain | S_TK_X | 3.36e-03 | 56 | 100 | 3 | SM00133 | |
| Domain | PH | 3.82e-03 | 278 | 100 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 3.89e-03 | 279 | 100 | 6 | PS50003 | |
| Domain | PH_domain | 3.96e-03 | 280 | 100 | 6 | IPR001849 | |
| Domain | PI3_PI4_kinase | 4.11e-03 | 18 | 100 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 4.11e-03 | 18 | 100 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.11e-03 | 18 | 100 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 4.11e-03 | 18 | 100 | 2 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 4.11e-03 | 18 | 100 | 2 | PS50290 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 4.57e-03 | 19 | 100 | 2 | IPR006553 | |
| Domain | LRR_CC | 4.57e-03 | 19 | 100 | 2 | SM00367 | |
| Domain | PWWP | 5.06e-03 | 20 | 100 | 2 | SM00293 | |
| Domain | CH | 5.12e-03 | 65 | 100 | 3 | SM00033 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH9 HACD3 NFASC FOCAD JAK2 MSH6 KMT2C MDN1 AHR ATM ZBTB11 UTRN PLXNB3 | 2.27e-07 | 736 | 101 | 13 | 29676528 |
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 10506199 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CYTH1 GRK5 GRK6 SFI1 GRIN2D MLXIP LDLR FOCAD JAK2 KMT2C ARHGEF40 MDN1 MEGF8 PIK3CD TTLL4 | 7.16e-07 | 1105 | 101 | 15 | 35748872 |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 8672451 | ||
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 11517230 | ||
| Pubmed | MYH9 AHCTF1 CHD1 RPL14 NSUN2 MSH6 MDN1 ATM ASCC3 ZBTB11 UTRN | 3.24e-06 | 653 | 101 | 11 | 22586326 | |
| Pubmed | Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. | 8.35e-06 | 2 | 101 | 2 | 23257360 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8812454 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 32901907 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27527345 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26820533 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 29317724 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17786238 | ||
| Pubmed | Biological Functions of the KDM2 Family of Histone Demethylases. | 8.35e-06 | 2 | 101 | 2 | 37751135 | |
| Pubmed | Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 V617F Mice. | 8.35e-06 | 2 | 101 | 2 | 30571460 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20038610 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 31363749 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 39125717 | ||
| Pubmed | Atypical, milder presentation in a child with CC2D2A and KIDINS220 variants. | 8.35e-06 | 2 | 101 | 2 | 31577543 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12399522 | ||
| Pubmed | 1.05e-05 | 15 | 101 | 3 | 19762545 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GAL3ST1 SMPD4 TMEM87A LDLR ELOVL7 FOCAD JAK2 MED24 MDN1 AHR ATP11C ATM IPO11 | 1.26e-05 | 1061 | 101 | 13 | 33845483 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HACD3 RFX1 NSUN2 MED24 MSH6 TBC1D10B MDN1 BRPF1 KDM2B ATM EXOC2 | 1.60e-05 | 774 | 101 | 11 | 15302935 |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 7789183 | ||
| Pubmed | G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway. | 2.50e-05 | 3 | 101 | 2 | 19801552 | |
| Pubmed | Involvement of RFX proteins in transcriptional activation from a Ras-responsive enhancer element. | 2.50e-05 | 3 | 101 | 2 | 15024578 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 12411430 | ||
| Pubmed | RFX transcription factors are essential for hearing in mice. | 2.50e-05 | 3 | 101 | 2 | 26469318 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 10330134 | ||
| Pubmed | Ciliogenic RFX transcription factors regulate FGF1 gene promoter. | 2.50e-05 | 3 | 101 | 2 | 22415835 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 30033217 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 9092566 | ||
| Pubmed | Drosophila regulatory factor X is necessary for ciliated sensory neuron differentiation. | 2.50e-05 | 3 | 101 | 2 | 12403718 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19842931 | ||
| Pubmed | Interplay of RFX transcription factors 1, 2 and 3 in motile ciliogenesis. | 2.50e-05 | 3 | 101 | 2 | 32725242 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 18662895 | ||
| Pubmed | Hepatic JAK2 protects against atherosclerosis through circulating IGF-1. | 2.50e-05 | 3 | 101 | 2 | 28724798 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 30025158 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 26004508 | ||
| Pubmed | Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. | 2.50e-05 | 3 | 101 | 2 | 12032308 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 20581153 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 32941808 | ||
| Pubmed | Expression of G-protein-coupled receptor kinases in pregnant term and non-pregnant human myometrium. | 2.50e-05 | 3 | 101 | 2 | 10467231 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 8289803 | ||
| Pubmed | Cigarette smoke extract stimulates PCSK9 production in HepG2 cells via ROS/NF‑κB signaling. | 2.50e-05 | 3 | 101 | 2 | 33760160 | |
| Pubmed | 2.57e-05 | 407 | 101 | 8 | 12693553 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 3.04e-05 | 21 | 101 | 3 | 27626377 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.36e-05 | 208 | 101 | 6 | 33230847 | |
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 3.50e-05 | 63 | 101 | 4 | 19351817 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11682486 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 29969579 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 21960563 | ||
| Pubmed | Differential expression of Rfx1-4 during mouse spermatogenesis. | 4.99e-05 | 4 | 101 | 2 | 19596083 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 31167772 | ||
| Pubmed | Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo. | 4.99e-05 | 4 | 101 | 2 | 24412615 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 30286201 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 10379886 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 38457657 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 15863839 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 23023391 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 21784156 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 21216307 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 20023040 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 11504827 | ||
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 23973224 | ||
| Pubmed | Histone demethylation by a family of JmjC domain-containing proteins. | 4.99e-05 | 4 | 101 | 2 | 16362057 | |
| Pubmed | Structural and functional evolution of the L1 family: are four adhesion molecules better than one? | 4.99e-05 | 4 | 101 | 2 | 10662501 | |
| Pubmed | 4.99e-05 | 4 | 101 | 2 | 30267961 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 24488984 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 28416579 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 12507501 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 18996356 | ||
| Pubmed | ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. | 8.30e-05 | 5 | 101 | 2 | 17084711 | |
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 24531968 | ||
| Pubmed | 8.30e-05 | 5 | 101 | 2 | 27232975 | ||
| Pubmed | RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. | 8.30e-05 | 5 | 101 | 2 | 8600444 | |
| Pubmed | Genetic variations and treatments that affect the lifespan of the NPC1 mouse. | 8.30e-05 | 5 | 101 | 2 | 18077828 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PLEKHB2 HACD3 AHCTF1 NSUN2 CERS5 MED24 TBC1D10B ARHGEF40 KIDINS220 ASCC3 IPO11 | 9.39e-05 | 942 | 101 | 11 | 31073040 |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 1.14e-04 | 374 | 101 | 7 | 19625176 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.23e-04 | 807 | 101 | 10 | 30575818 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 12111378 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 9826657 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 9211925 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 22043923 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 21088116 | ||
| Pubmed | Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. | 1.24e-04 | 6 | 101 | 2 | 23663738 | |
| Pubmed | beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. | 1.24e-04 | 6 | 101 | 2 | 20530803 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 17060617 | ||
| Pubmed | Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway. | 1.24e-04 | 6 | 101 | 2 | 24357053 | |
| Pubmed | Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals. | 1.24e-04 | 6 | 101 | 2 | 18097620 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 38701199 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 29627294 | ||
| Pubmed | ATM-mediated KDM2A phosphorylation is required for the DNA damage repair. | 1.24e-04 | 6 | 101 | 2 | 25823024 | |
| Pubmed | Genome-wide association study of multiplex schizophrenia pedigrees. | 1.24e-04 | 6 | 101 | 2 | 22885689 | |
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 17329566 | ||
| Pubmed | 1.24e-04 | 6 | 101 | 2 | 36451830 | ||
| Pubmed | 1.27e-04 | 381 | 101 | 7 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 1.30e-04 | 382 | 101 | 7 | 19170196 | |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 1.33e-04 | 34 | 101 | 3 | 25925205 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 HACD3 AHCTF1 CHD1 RPL14 NSUN2 MSH6 ARHGEF40 MDN1 KDM2A EXOC2 ASCC3 UTRN | 1.50e-04 | 1353 | 101 | 13 | 29467282 |
| Interaction | EDNRB interactions | 1.37e-06 | 39 | 100 | 5 | int:EDNRB | |
| Interaction | GPR182 interactions | MMS22L AHCTF1 SMPD4 TMEM87A FOCAD CERS5 KIDINS220 MDN1 SURF1 ATM EXOC2 IPO11 | 2.64e-06 | 455 | 100 | 12 | int:GPR182 |
| Interaction | SCN2B interactions | 7.81e-06 | 95 | 100 | 6 | int:SCN2B | |
| Cytoband | 9p24 | 1.33e-04 | 8 | 101 | 2 | 9p24 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.34e-04 | 206 | 69 | 6 | 682 | |
| GeneFamily | PHD finger proteins | 3.88e-04 | 90 | 69 | 4 | 88 | |
| GeneFamily | Regulatory factor X family | 3.96e-04 | 8 | 69 | 2 | 1153 | |
| GeneFamily | Zinc fingers CXXC-type | 9.24e-04 | 12 | 69 | 2 | 136 | |
| GeneFamily | ATP binding cassette subfamily A | 1.27e-03 | 14 | 69 | 2 | 805 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.88e-03 | 21 | 69 | 2 | 558 | |
| GeneFamily | PWWP domain containing | 3.16e-03 | 22 | 69 | 2 | 1147 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.75e-03 | 24 | 69 | 2 | 485 | |
| GeneFamily | Cyclins|Mediator complex | 7.02e-03 | 33 | 69 | 2 | 1061 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MICAL1 MYH9 CYTH1 GRK6 CHD1 RPL14 LAX1 EPG5 KMT2C KIDINS220 ST3GAL5 PIK3CD TRPV2 AHR KDM2A ATM GNAS ASCC3 UTRN | 2.33e-06 | 1492 | 98 | 19 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.24e-06 | 180 | 98 | 7 | M8239 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 8.85e-06 | 195 | 98 | 7 | M7397 | |
| Coexpression | GSE15767_MED_VS_SCS_MAC_LN_DN | 1.01e-05 | 199 | 98 | 7 | M3585 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CYTH1 AHCTF1 GRK5 CHD1 TMEM87A LDLR MSH6 KIDINS220 MDN1 ST3GAL5 ARHGAP12 ASCC3 ZBTB11 | 1.82e-05 | 856 | 98 | 13 | M4500 |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP | 5.66e-05 | 178 | 98 | 6 | M383 | |
| Coexpression | PTEN_DN.V1_UP | 7.22e-05 | 186 | 98 | 6 | M2787 | |
| Coexpression | TGFB_UP.V1_UP | 7.88e-05 | 189 | 98 | 6 | M2839 | |
| Coexpression | HASLINGER_B_CLL_WITH_11Q23_DELETION | 8.50e-05 | 23 | 98 | 3 | M11509 | |
| Coexpression | GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN | 1.02e-04 | 198 | 98 | 6 | M3273 | |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP | 1.02e-04 | 198 | 98 | 6 | M4727 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN | 1.02e-04 | 198 | 98 | 6 | M5701 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP | 1.05e-04 | 199 | 98 | 6 | M8964 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKCELL_UP | 1.05e-04 | 199 | 98 | 6 | M4836 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 1.06e-04 | 498 | 98 | 9 | M1741 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 1.08e-04 | 200 | 98 | 6 | M9458 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN | 1.08e-04 | 200 | 98 | 6 | M7296 | |
| Coexpression | GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN | 1.08e-04 | 200 | 98 | 6 | M5560 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.08e-04 | 200 | 98 | 6 | M9133 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 1.21e-04 | 507 | 98 | 9 | MM1030 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-07 | 166 | 101 | 7 | a2ce44702a0cd5fa5872cac3302d3c451205feef | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-07 | 166 | 101 | 7 | 0f641302a6b71c4badaaf20f51162bfc2386b167 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.37e-07 | 187 | 101 | 7 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.46e-07 | 188 | 101 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.49e-07 | 198 | 101 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.73e-07 | 200 | 101 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.59e-06 | 171 | 101 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-06 | 173 | 101 | 6 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Ionocyte-iono-2|World / Class top | 2.78e-06 | 173 | 101 | 6 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.76e-06 | 190 | 101 | 6 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.06e-06 | 192 | 101 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-06 | 196 | 101 | 6 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 6.03e-06 | 198 | 101 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.39e-06 | 200 | 101 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 160 | 101 | 5 | 0b8151037b28f52a21918856a1e9336e8d5edb90 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 160 | 101 | 5 | 4738d0c73d8c3508e5b5beb6c61e0ad551d9b949 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 164 | 101 | 5 | cd0794f84dfd346807e2d803723718b7f22e9232 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-05 | 164 | 101 | 5 | 12251a49fd4af32d4edb58046245548c260cf04b | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 164 | 101 | 5 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-05 | 165 | 101 | 5 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-05 | 165 | 101 | 5 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-05 | 165 | 101 | 5 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 4.17e-05 | 169 | 101 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Ionocyte-iono-1|World / Class top | 4.17e-05 | 169 | 101 | 5 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Ionocyte|World / Class top | 4.29e-05 | 170 | 101 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 4.29e-05 | 170 | 101 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-05 | 175 | 101 | 5 | bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma-schwann_cells|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-05 | 175 | 101 | 5 | 8b010220cdfb680ec839572f4933adfb85045ea6 | |
| ToppCell | 10x3'2.3-week_17-19-Neuro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.92e-05 | 175 | 101 | 5 | 0b579aeadcc06be83627391c0b01bd8605fdbdf3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.48e-05 | 179 | 101 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.25e-05 | 184 | 101 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 184 | 101 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 6.25e-05 | 184 | 101 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.25e-05 | 184 | 101 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.41e-05 | 185 | 101 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.41e-05 | 185 | 101 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.57e-05 | 186 | 101 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.74e-05 | 187 | 101 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.74e-05 | 187 | 101 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-05 | 189 | 101 | 5 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.09e-05 | 189 | 101 | 5 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 7.27e-05 | 190 | 101 | 5 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 7.27e-05 | 190 | 101 | 5 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.45e-05 | 191 | 101 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.64e-05 | 192 | 101 | 5 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | IPF-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 7.64e-05 | 192 | 101 | 5 | 356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.64e-05 | 192 | 101 | 5 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.64e-05 | 192 | 101 | 5 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.64e-05 | 192 | 101 | 5 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 7.82e-05 | 193 | 101 | 5 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.82e-05 | 193 | 101 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.62e-05 | 197 | 101 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.62e-05 | 197 | 101 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.62e-05 | 197 | 101 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.83e-05 | 198 | 101 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.83e-05 | 198 | 101 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.04e-05 | 199 | 101 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.04e-05 | 199 | 101 | 5 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.04e-05 | 199 | 101 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-05 | 199 | 101 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.25e-05 | 200 | 101 | 5 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.25e-05 | 200 | 101 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal-Cilia-bearing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.25e-05 | 200 | 101 | 5 | c6060205cab46628d845edbf17e2c5be7508181c | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Drug | Imipenem [74431-23-5]; Up 200; 13.4uM; HL60; HG-U133A | 3.10e-06 | 200 | 101 | 8 | 1724_UP | |
| Disease | Intellectual Disability | CHL1 GRIN2D NSUN2 KMT2C ST3GAL5 SURF1 MED12L GNAS ASCC3 ZBTB11 | 2.46e-06 | 447 | 98 | 10 | C3714756 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 7.23e-06 | 139 | 98 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | CHL1 ABCA4 AMACR CHD1 ABCA8 MSH6 KMT2C ATP11C KDM2A GNAS ABCC2 | 2.19e-05 | 702 | 98 | 11 | C0009402 |
| Disease | Non-alcoholic Fatty Liver Disease | 8.87e-05 | 70 | 98 | 4 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 8.87e-05 | 70 | 98 | 4 | C3241937 | |
| Disease | obsessive-compulsive symptom measurement | 1.49e-04 | 31 | 98 | 3 | EFO_0007802 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 2.27e-04 | 7 | 98 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | MASA syndrome (implicated_via_orthology) | 2.27e-04 | 7 | 98 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | endometrial cancer (is_implicated_in) | 2.34e-04 | 36 | 98 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.54e-04 | 37 | 98 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 3.31e-04 | 277 | 98 | 6 | C0009404 | |
| Disease | Liver Diseases, Parasitic | 3.87e-04 | 9 | 98 | 2 | C0023897 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 3.98e-04 | 43 | 98 | 3 | DOID:9261 (is_marker_for) | |
| Disease | Gastric Adenocarcinoma | 4.56e-04 | 45 | 98 | 3 | C0278701 | |
| Disease | Atrophic | 4.83e-04 | 10 | 98 | 2 | C0333641 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 5.86e-04 | 49 | 98 | 3 | EFO_0021897 | |
| Disease | Schizophrenia | 7.13e-04 | 883 | 98 | 10 | C0036341 | |
| Disease | leukemia | 8.22e-04 | 55 | 98 | 3 | C0023418 | |
| Disease | Diffuse Large B-Cell Lymphoma | 8.22e-04 | 55 | 98 | 3 | C0079744 | |
| Disease | melanoma | 8.40e-04 | 126 | 98 | 4 | EFO_0000756 | |
| Disease | Prostatic Neoplasms | 1.05e-03 | 616 | 98 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.05e-03 | 616 | 98 | 8 | C0376358 | |
| Disease | lymphocyte count | MMS22L GRK5 SPTB SFI1 PLEKHA6 LAX1 FOCAD CERS5 ST3GAL5 PIK3CD MED12L ATM CLCF1 | 1.11e-03 | 1464 | 98 | 13 | EFO_0004587 |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0010367 | |
| Disease | Profound Mental Retardation | 1.21e-03 | 139 | 98 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.21e-03 | 139 | 98 | 4 | C0025363 | |
| Disease | Mental deficiency | 1.21e-03 | 139 | 98 | 4 | C0917816 | |
| Disease | response to antineoplastic agent, response to antimicrotubule agent | 1.27e-03 | 16 | 98 | 2 | EFO_0005260, GO_0097327 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.27e-03 | 16 | 98 | 2 | C0334634 | |
| Disease | mean reticulocyte volume | 1.38e-03 | 799 | 98 | 9 | EFO_0010701 | |
| Disease | breast carcinoma (is_marker_for) | 1.40e-03 | 66 | 98 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Tachycardia | 1.61e-03 | 18 | 98 | 2 | C0039231 | |
| Disease | Tachyarrhythmia | 1.61e-03 | 18 | 98 | 2 | C0080203 | |
| Disease | cholesteryl ester measurement | 1.69e-03 | 257 | 98 | 5 | EFO_0010351 | |
| Disease | Liver diseases | 1.79e-03 | 72 | 98 | 3 | C0023895 | |
| Disease | Liver Dysfunction | 1.79e-03 | 72 | 98 | 3 | C0086565 | |
| Disease | mean platelet volume | 2.09e-03 | 1020 | 98 | 10 | EFO_0004584 | |
| Disease | epilepsy (implicated_via_orthology) | 2.17e-03 | 163 | 98 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 2.42e-03 | 22 | 98 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | colorectal carcinoma (is_implicated_in) | 2.42e-03 | 22 | 98 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | risky sexual behaviour measurement | 2.47e-03 | 169 | 98 | 4 | EFO_0007877 | |
| Disease | Immunologic Deficiency Syndromes | 2.64e-03 | 23 | 98 | 2 | C0021051 | |
| Disease | QRS duration, response to sulfonylurea | 2.64e-03 | 23 | 98 | 2 | EFO_0005055, EFO_0007922 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.87e-03 | 24 | 98 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.87e-03 | 24 | 98 | 2 | C3805278 | |
| Disease | Dyslipidemias | 2.87e-03 | 24 | 98 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.87e-03 | 24 | 98 | 2 | C0598784 | |
| Disease | myeloproliferative disorder | 3.12e-03 | 25 | 98 | 2 | EFO_0004251 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRLLTKNNRWTWVQS | 351 | P35869 | |
| QWAWNLILRLKLHKN | 966 | Q9HCE0 | |
| KLFLWWHQVLQLSLI | 2416 | Q9HCE0 | |
| LKWTSSIAQLLWRQA | 1361 | Q8TER5 | |
| ILLKWLSNFSVFWKS | 161 | Q96P56 | |
| ADKEFVWSLWKRLQV | 121 | Q9NXG0 | |
| QIQLLLWKNWTLRKR | 6 | P78363 | |
| WKKVIWIYLSALNSA | 86 | Q4VNC1 | |
| LSSFLWKTQKLSLWE | 191 | Q9UHK6 | |
| RWQKIFSFNVWGKIA | 31 | Q9UHQ4 | |
| EVWLTFQQKWIFLNK | 1256 | Q96M86 | |
| LQVRRSFKTWWQKKP | 2781 | Q96M86 | |
| IKQWRKNLWIFVSKF | 1471 | O14646 | |
| LSKQLDWNVRKIQCW | 111 | Q8N5B7 | |
| KKLQWLVSAWSQCSV | 1051 | Q8TE57 | |
| NILWKLEVAKQLAWA | 646 | O60674 | |
| IDVWKKWTTLNSLQL | 281 | Q08J23 | |
| WKRWKKRFFVLVQVS | 536 | Q9ULU8 | |
| WWQVLDSLLNSQRKR | 711 | Q9ULH0 | |
| VASQWTLKKSLLQAW | 2851 | Q9NU22 | |
| WTTRVKQIAKLWRKA | 1671 | Q8NEZ4 | |
| WTLRQSWLELQLMIK | 1321 | Q86YW9 | |
| RLKGYQINWWKTKSL | 841 | O00533 | |
| QINWWKTKSLLDGRT | 846 | O00533 | |
| TVQKKVSQWWERLTK | 81 | Q9P035 | |
| FVSESFWNWLNKLLK | 311 | Q6ZRQ5 | |
| FWNWLNKLLKTLLEK | 316 | Q6ZRQ5 | |
| WFTNSWVLKRKRTPQ | 691 | A6NM62 | |
| VIWLIGQWISVKFKS | 496 | Q9UI26 | |
| VLSREASQKLLWWLQ | 281 | Q53F39 | |
| LLNAWRLVNAAKIWT | 466 | Q16549 | |
| TLHIWKTNSLLLRFW | 1746 | Q9ULL4 | |
| TKLVLSQLPNFWKLW | 456 | Q96KP1 | |
| LWLLKKSNRYSLTIW | 216 | Q6UXP7 | |
| KTWKRRWFILTDNCL | 276 | Q15438 | |
| FWVLNLTTLQWRQEK | 1596 | Q7Z7M0 | |
| VVAVFCILWNWNKRK | 51 | Q8IWV1 | |
| TKSWFWTRLAKALSL | 281 | Q99836 | |
| IKDQLNYWSAKSLWT | 51 | Q8TDZ2 | |
| QKNSWFLSLFWILSI | 126 | Q92887 | |
| QWWRLFTKVKPLLQV | 826 | P35579 | |
| RKWWQIKSQNFDLVI | 411 | P52701 | |
| LQTKQRRPSKDIAWW | 11 | Q9NZI2 | |
| QNFISESWRKKWNVI | 266 | Q68CR7 | |
| RRATLWIPQWFAKKA | 16 | Q9NXE4 | |
| KVRKNWLSSWAVLQG | 481 | Q8IWW6 | |
| TRTLQNWKFWIFSII | 826 | Q9HAP2 | |
| WRESSLLKNLWVSQK | 866 | O94856 | |
| ANLWVTKLWKFIRDF | 406 | Q99999 | |
| LKLWNKIWCITFRGI | 481 | Q13315 | |
| LAQVSWIKNRVLKKW | 366 | P15812 | |
| WTNISKKQLTWLVNR | 961 | Q9Y2K7 | |
| LSWTNISKKQLSWLI | 1131 | Q8NHM5 | |
| TSLQQWKAWRKVQRA | 576 | Q9P2K1 | |
| LWWKKYLTSLQLVQF | 201 | A1L3X0 | |
| QRIISWVFFWRQKIK | 16 | Q8IZ16 | |
| EKWKQNAPTLARWAI | 111 | Q86VX2 | |
| NLFKSIWNNRWLRTI | 271 | P63092 | |
| LLRNWSKSKKWFLEL | 211 | Q9NYL5 | |
| IFKDLKLRGFWLSQW | 301 | Q9BV79 | |
| RFVLEWTWNKVVLTK | 581 | Q8WYP5 | |
| FLQWKWLERQPVTKN | 171 | P32298 | |
| LQWKWLERQPVTKNT | 171 | P34947 | |
| LQWKWLERQPVTKNT | 171 | P43250 | |
| WWEFNVHSKLKLVRQ | 111 | Q66K64 | |
| WKRFLKNNWVLLSTV | 11 | P43005 | |
| WKEQTQKFIDWLFSI | 1746 | Q5VW36 | |
| KKSRWNVLKCWDIFN | 371 | P0C7A2 | |
| SKAWLIRWSLLVQDK | 1251 | Q9P2P1 | |
| WGNKTLKQTFLSVLW | 281 | P59543 | |
| WGNKKLKQTFLSVLW | 281 | P59540 | |
| SLQAKVWATWLAFVL | 851 | A8K8P3 | |
| NRIVTIIQKWWRSFL | 56 | Q96L03 | |
| SAELLNWILKWKTAI | 696 | P46939 | |
| NWILKWKTAIQTTEI | 701 | P46939 | |
| RQSTILKRWKKNWFD | 11 | Q96CS7 | |
| QRWLVRFKTIFKQVW | 361 | Q7L1I2 | |
| LQFTLVETLWKTFWR | 626 | P22670 | |
| LQFSLIEKLWQTFWR | 371 | P48380 | |
| FRNKLWNWEKVSSQK | 136 | Q5VWT5 | |
| FKSIWNNRWLRTISV | 916 | Q5JWF2 | |
| LKQAILQAWKERWSD | 6 | O75448 | |
| WVRLFFWKQVAEKIP | 286 | Q9UNP4 | |
| LGTWQVQRRKWKLNL | 76 | Q15526 | |
| QLLKESLWKISDVAW | 576 | Q7Z745 | |
| QTWALLCKNFLKKWR | 11 | O94911 | |
| NWALKEQLKSWQRLR | 581 | P55201 | |
| NLSKVIDKRLWGWAS | 1111 | Q8N3C0 | |
| ASLLAWRMFQKWIKA | 196 | Q9UGN4 | |
| LQTWLWRSAKDFNRL | 191 | Q9UBD9 | |
| TLKLALDTRFWTWIN | 1011 | Q8NB49 | |
| SSGVKQWNKRWFVLV | 71 | Q9Y2H5 | |
| LSKTYWWRGILKQVK | 96 | O95625 | |
| LLLFSWKTVKQNEIW | 451 | Q8IUR5 | |
| DINTKWAATRWAKKI | 81 | P50914 | |
| KWNRLLQKGWVDLFV | 291 | P05543 | |
| SWSIWKLQKAISVLE | 656 | Q9Y5S1 | |
| EALRESWKTKVNWLA | 1021 | O00329 | |
| NWDKWLSRRFQKVKL | 341 | Q4KMP7 | |
| NVNLIRFWVELQKWK | 1681 | P08922 | |
| AQLEQSKRLWKFFWE | 631 | P11277 | |
| LAIAQVWLWVSLAKA | 36 | Q6UXP9 | |
| FWKKGNVRITLFWTV | 191 | Q9H0C3 | |
| TIIWRTKWENNNKAL | 396 | Q9NUQ3 | |
| LRKAWESSSRQKWIV | 706 | Q14679 | |
| RIKSRIPKWQWQLES | 696 | Q07283 | |
| WWIFISLTQTMKLLK | 376 | Q8NBN3 | |
| VFLLWKNWRLKNINS | 806 | P01130 | |
| KSIWLLWALVFNNSV | 631 | O15399 |